Accumetrics Signs National Distribution Agreement with Cardinal Health (CAH)

Accumetrics, Inc., marketer of the VerifyNow System, the first rapid and easy-to-use point-of-care diagnostic system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the company has signed a national distribution agreement with Cardinal Health CAH to distribute the VerifyNow System to hospitals, health systems and independent laboratories throughout the United States. The VerifyNow System is widely used by physicians to assess patients' platelet response to various antiplatelet therapies such as aspirin, Plavix® and Effient®.  Up to one in three individuals may not be responding adequately to their antiplatelet therapy.  Patients with poor response to their anti-platelet therapy may be at significantly greater risk of adverse events. "We anticipate a more rapid adoption of the VerifyNow System as a result of this agreement with Cardinal Health," said Timothy I. Still, President and CEO of Accumetrics.  "Cardinal's record of outpacing market growth is well-documented."